Belimumab, a human mAb that inhibits B-cell-activating factor (BAFF) has been successfully used in the treatment of cytopenia in patients with systemic lupus erythematosus (SLE) (46). The gene discussed is TNFSF13B; the disease is systemic lupus erythematosus.